Annual Debt To Equity
-0.20
-0.05-33.33%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual debt to equity ratio is -0.20, with the most recent change of -0.05 (-33.33%) on December 31, 2023.
- During the last 3 years, CHRO annual debt to equity has fallen by -0.13 (-185.71%).
Performance
CHRO Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-1.60
+7.10+81.61%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly debt to equity ratio is -1.60, with the most recent change of +7.10 (+81.61%) on September 30, 2024.
- Over the past year, CHRO quarterly debt to equity has dropped by -1.40 (-700.00%).
- CHRO quarterly debt to equity is now -16100.00% below its all-time high of 0.01, reached on September 1, 2022.
Performance
CHRO Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
CHRO Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.3% | -700.0% |
| 3 y3 years | -185.7% | -10000.0% |
| 5 y5 years | -185.7% | -10000.0% |
CHRO Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | <-9999.0% | +81.6% |
| 5 y | 5-year | <-9999.0% | at low | <-9999.0% | +81.6% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +81.6% |
Chromocell Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1.60(-81.6%) |
| Jun 2024 | - | -8.70(+4250.0%) |
| Dec 2023 | -0.20 | -0.20(0.0%) |
| Sep 2023 | - | -0.20(0.0%) |
| Jun 2023 | - | -0.20(+17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -0.17(+13.3%) |
| Dec 2022 | -0.15(<-9900.0%) | -0.15(-1600.0%) |
| Sep 2022 | - | 0.01(>+9900.0%) |
| Dec 2021 | 0.00(-100.0%) | 0.00 |
| Dec 2020 | -0.07 | - |
FAQ
- What is Chromocell Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual debt to equity year-on-year change?
- What is Chromocell Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly debt to equity year-on-year change?
What is Chromocell Therapeutics annual debt to equity ratio?
The current annual debt to equity of CHRO is -0.20
What is the all time high annual debt to equity for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual debt to equity ratio is 0.00
What is Chromocell Therapeutics annual debt to equity year-on-year change?
Over the past year, CHRO annual debt to equity ratio has changed by -0.05 (-33.33%)
What is Chromocell Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of CHRO is -1.60
What is the all time high quarterly debt to equity for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly debt to equity ratio is 0.01
What is Chromocell Therapeutics quarterly debt to equity year-on-year change?
Over the past year, CHRO quarterly debt to equity ratio has changed by -1.40 (-700.00%)